In our cohort, the most common presenting symptoms were ptosis, diplopia, and generalized weakness in the AChR-Abs and triple-SN-MG-Abs groups and ptosis, diplopia, dysphagia, and dysphonia in the MuSK-Abs MG group. Here, MGAM is linked to myasthenia gravis.